Retinal Biologics Market Poised for Explosive Growth at 11.1% CAGR, Reaching US$41.9 Billion by 2028 | FMI Research Report

The Retinal Biologics Market is experiencing a surge in demand, fueled by advancements in eye disease treatments and a growing emphasis on vision health. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is currently valued at an impressive US$22.25 billion in 2022. Looking ahead, the market …

Global Retinal Biologics Industry Poised for US$41.92 Billion by 2028, Growing at 11.1% CAGR | FMI Insights

The Global Retinal Biologics Industry is experiencing remarkable growth, with an anticipated value of more than US$ 22.25 billion by 2022, set to further expand to US$ 41.92 billion by 2028, marking an impressive 11.1% Compound Annual Growth Rate (CAGR) between 2022 and 2028. Key Market Insights: Rising Prevalence of Diabetes-related Eye Disorders and Age-related …